Observational study on gene mutation and prognosis for patients with resectable pancreatic cancer
Not Applicable
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000032917
- Lead Sponsor
- Kobe university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 219
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not participate in this research from published information Patients under 20 years of age
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between gene mutation (KRAS, TP53, CDKN2A, SMAD4) and prognosis in patients with surgically treated pancreatic cancer
- Secondary Outcome Measures
Name Time Method The relationship between the following items and the relation between gene mutation or prognosis in pancreatic cancer patients who underwent surgical treatment 1)presence or absence of IPMN coexistence 2)desmoplastic change 3)diabetic status 4)smoking history 5)local immune responses(TIL:Tumor Infiltrating Lymphocyte, TLS:Tertiary Lymphoid Structure ) 6)systemic immune responses(ALC:Absolute Lymphocyte Counts, ANC:Absolute Neutrophil Counts, NLR:Neutrophil-to-Lymphocyte Ratio) The relationship between desmoplastic change and preoperative image findings